International Journal of Radiation Oncology * Biology * Physics
Volume 64, Issue 4 , Pages 1055-1059, 15 March 2006

Dose to the intracranial arteries in stereotactic and intensity-modulated radiotherapy for skull base tumors

  • Carsten Nieder, M.D.

      Affiliations

    • Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
    • Corresponding Author InformationReprint requests to: Carsten Nieder, M.D., Department of Radiation Oncology, Klinikum rechts der Isar, T.U. Munich, Ismaninger Str. 22, 81675 Munich, Germany. Tel: (+49) 89-4140-4501; Fax: (+49) 89-4140-4300
  • ,
  • Anca L. Grosu, M.D.

      Affiliations

    • Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  • ,
  • Sybille Stark, M.Sc.

      Affiliations

    • Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  • ,
  • Nicole Wiedenmann, M.D.

      Affiliations

    • Department of Experimental Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
  • ,
  • Raymonde Busch, M.Sc.

      Affiliations

    • Institute for Medical Statistics and Epidemiology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  • ,
  • Peter Kneschaurek, Ph.D.

      Affiliations

    • Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  • ,
  • Michael Molls, M.D.

      Affiliations

    • Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany

Received 20 July 2005; received in revised form 14 September 2005; accepted 14 September 2005. published online 12 December 2005.

Purpose: To examine retrospectively the maximum dose to the large skull base/intracranial arteries in fractionated stereotactic radiotherapy (FSRT) and intensity-modulated radiotherapy (IMRT), because of the potential risk of perfusion disturbances.

Methods and Materials: Overall, 56 patients with tumors adjacent to at least one major artery were analyzed. Our strategy was to perform FSRT with these criteria: 1.8 Gy per fraction, planning target volume (PTV) enclosed by the 95% isodose, maximum dose 107%. Dose limits were applied to established organs at risk, but not the vessels. If FSRT planning failed to meet any of these criteria, IMRT was planned with the same objectives.

Results: In 31 patients (median PTV, 23 cm3), the FSRT plan fulfilled all criteria. No artery received a dose ≥105%. Twenty-five patients (median PTV, 39 cm3) needed IMRT planning. In 11 of 25 patients (median PTV, 85 cm3), no plan satisfying all our criteria could be calculated. Only in this group, moderately increased maximum vessel doses were observed (106–110%, n = 7, median PTV, 121 cm3). The median PTV dose gradient was 29% (significantly different from the 14 patients with satisfactory IMRT plans). Three of the four patients in this group had paranasal sinus tumors.

Conclusion: The doses to the major arteries should be calculated in IMRT planning for critical tumor locations if a dose gradient >13% within the PTV can not be avoided because the PTV is large or includes air cavities.

Keywords:  Intensity-modulated radiotherapy , Stereotactic radiotherapy , Skull base tumor , Brain tumor , Intracranial blood vessel

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by the Bavarian State Ministry of Environment, Public Health, and Consumer Protection.

PII: S0360-3016(05)02606-4

doi:10.1016/j.ijrobp.2005.09.015

International Journal of Radiation Oncology * Biology * Physics
Volume 64, Issue 4 , Pages 1055-1059, 15 March 2006